Logo image of OWLT

OWLET INC (OWLT) Stock Fundamental Analysis

NYSE:OWLT - New York Stock Exchange, Inc. - US69120X2062 - Common Stock - Currency: USD

7.16  -0.19 (-2.59%)

Fundamental Rating

2

Taking everything into account, OWLT scores 2 out of 10 in our fundamental rating. OWLT was compared to 187 industry peers in the Health Care Equipment & Supplies industry. OWLT may be in some trouble as it scores bad on both profitability and health. OWLT shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

OWLT had negative earnings in the past year.
In the past year OWLT has reported a negative cash flow from operations.
OWLT had negative earnings in each of the past 5 years.
OWLT had a negative operating cash flow in each of the past 5 years.
OWLT Yearly Net Income VS EBIT VS OCF VS FCFOWLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

The Return On Assets of OWLT (-30.18%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -30.18%
ROE N/A
ROIC N/A
ROA(3y)-85.43%
ROA(5y)-66.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OWLT Yearly ROA, ROE, ROICOWLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

OWLT has a Gross Margin (51.06%) which is comparable to the rest of the industry.
OWLT's Gross Margin has improved in the last couple of years.
OWLT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.89%
GM growth 5Y1.83%
OWLT Yearly Profit, Operating, Gross MarginsOWLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

OWLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
OWLT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for OWLT has been increased compared to 5 years ago.
Compared to 1 year ago, OWLT has an improved debt to assets ratio.
OWLT Yearly Shares OutstandingOWLT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M
OWLT Yearly Total Debt VS Total AssetsOWLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

OWLT has an Altman-Z score of -5.43. This is a bad value and indicates that OWLT is not financially healthy and even has some risk of bankruptcy.
OWLT has a Altman-Z score of -5.43. This is in the lower half of the industry: OWLT underperforms 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.43
ROIC/WACCN/A
WACC10.46%
OWLT Yearly LT Debt VS Equity VS FCFOWLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M -80M

2.3 Liquidity

OWLT has a Current Ratio of 1.19. This is a normal value and indicates that OWLT is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of OWLT (1.19) is worse than 83.96% of its industry peers.
OWLT has a Quick Ratio of 1.19. This is a bad value and indicates that OWLT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.90, OWLT is doing worse than 80.75% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.9
OWLT Yearly Current Assets VS Current LiabilitesOWLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

7

3. Growth

3.1 Past

OWLT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 93.79%, which is quite impressive.
The Revenue has grown by 70.89% in the past year. This is a very strong growth!
OWLT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.40% yearly.
EPS 1Y (TTM)93.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.05%
Revenue 1Y (TTM)70.89%
Revenue growth 3Y0.96%
Revenue growth 5Y9.4%
Sales Q2Q%43.05%

3.2 Future

Based on estimates for the next years, OWLT will show a very strong growth in Earnings Per Share. The EPS will grow by 31.27% on average per year.
OWLT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.96% yearly.
EPS Next Y-39.95%
EPS Next 2Y33.66%
EPS Next 3Y33.06%
EPS Next 5Y31.27%
Revenue Next Year22.84%
Revenue Next 2Y23.03%
Revenue Next 3Y24.37%
Revenue Next 5Y27.96%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OWLT Yearly Revenue VS EstimatesOWLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50M 100M 150M 200M 250M
OWLT Yearly EPS VS EstimatesOWLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -2 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

OWLT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year OWLT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OWLT Price Earnings VS Forward Price EarningsOWLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OWLT Per share dataOWLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

OWLT's earnings are expected to grow with 33.06% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.66%
EPS Next 3Y33.06%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OWLT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OWLET INC

NYSE:OWLT (6/25/2025, 12:15:19 PM)

7.16

-0.19 (-2.59%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-11 2025-08-11/amc
Inst Owners48.96%
Inst Owner Change3.07%
Ins Owners6.03%
Ins Owner Change-0.39%
Market Cap118.28M
Analysts82.22
Price Target11.05 (54.33%)
Short Float %2.45%
Short Ratio6.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)80.78%
Min EPS beat(2)74.89%
Max EPS beat(2)86.67%
EPS beat(4)4
Avg EPS beat(4)93.46%
Min EPS beat(4)74.89%
Max EPS beat(4)112.26%
EPS beat(8)4
Avg EPS beat(8)-16.31%
EPS beat(12)7
Avg EPS beat(12)-8.05%
EPS beat(16)7
Avg EPS beat(16)-20.76%
Revenue beat(2)2
Avg Revenue beat(2)15.75%
Min Revenue beat(2)14.03%
Max Revenue beat(2)17.47%
Revenue beat(4)3
Avg Revenue beat(4)9.39%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)17.47%
Revenue beat(8)3
Avg Revenue beat(8)-4.12%
Revenue beat(12)3
Avg Revenue beat(12)-5.92%
Revenue beat(16)5
Avg Revenue beat(16)-11.7%
PT rev (1m)6.56%
PT rev (3m)-7.8%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.56%
EPS NY rev (1m)7.33%
EPS NY rev (3m)38.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.95%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.19
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.88
FCFYN/A
OCF(TTM)-0.84
OCFYN/A
SpS6
BVpS-0.73
TBVpS-0.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.18%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.06%
FCFM N/A
ROA(3y)-85.43%
ROA(5y)-66.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.89%
GM growth 5Y1.83%
F-Score5
Asset Turnover1.93
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 176.84%
Cap/Sales 0.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 0.9
Altman-Z -5.43
F-Score5
WACC10.46%
ROIC/WACCN/A
Cap/Depr(3y)95.31%
Cap/Depr(5y)117.31%
Cap/Sales(3y)1.12%
Cap/Sales(5y)1.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%82.05%
EPS Next Y-39.95%
EPS Next 2Y33.66%
EPS Next 3Y33.06%
EPS Next 5Y31.27%
Revenue 1Y (TTM)70.89%
Revenue growth 3Y0.96%
Revenue growth 5Y9.4%
Sales Q2Q%43.05%
Revenue Next Year22.84%
Revenue Next 2Y23.03%
Revenue Next 3Y24.37%
Revenue Next 5Y27.96%
EBIT growth 1Y2.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year111.79%
EBIT Next 3Y37.31%
EBIT Next 5Y30.32%
FCF growth 1Y77.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.22%
OCF growth 3YN/A
OCF growth 5YN/A